⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL296978 | 0.95 | — | — | |
| SCHEMBL691844 | 0.95 | — | — | |
| SCHEMBL11124502 | 0.95 | — | — | |
| SCHEMBL10776388 | 0.84 | — | — | |
| SCHEMBL8900959 | 0.50 | — | — | |
| SCHEMBL19894436 | 0.47 | — | — | |
| Ethane SCHEMBL9395318 | 0.42 | — | — | |
| Cyclopropane SCHEMBL7188678 | 0.42 | — | — | |
| Cyclohexane SCHEMBL12475590 | 0.42 | — | — | |
| Cyclooctane SCHEMBL8564806 | 0.42 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114539176-B | Substituted triazine compound, preparation method thereof and application thereof in aldose detection | 中国海洋大学 | 2023-09-19 | — | — | CN | claimed |
| CN-114560819-B | Substituted triazine compound, preparation method thereof and application thereof in amino acid, peptide, protein and cell marker | 中国海洋大学 | 2023-09-19 | — | — | CN | claimed |
| EP-3157920-B1 | INDOLIZINE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS | CHIESI FARM SPA (IT) | 2019-08-07 | — | — | EP | claimed |
| US-9527869-B2 | Indolizine derivatives as phoshoinositide 3-kinases inhibitors | CHIESI FARMACEUTICI S.P.A. (IT) | 2016-12-27 | — | — | US | claimed |
| US-20150361100-A1 | INDOLIZINE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2015-12-17 | — | — | US | claimed |
| EP-1268421-B1 | PHENYL-SUBSTITUTED INDOLES AS HISTAMINE H3-RECEPTOR ANTAGONISTS | ORTHO MCNEIL PHARM INC (US) | 2009-05-06 | — | — | EP | claimed |
| US-6632823-B1 | Substituted pyridine compounds useful as modulators of acetylcholine receptors | MERCK & CO., INC. | 2003-10-14 | — | — | US | claimed |
| EP-1043999-A4 | NOVEL SUBSTITUTED PYRIDINE COMPOUNDS USEFUL AS MODULATORS OF ACETYLCHOLINE RECEPTORS | MERCK & CO INC (US) | 2003-04-23 | — | — | EP | claimed |
| EP-1268421-A2 | PHENYL-SUBSTITUTED INDOLES AS HISTAMINE H3-RECEPTOR ANTAGONISTS | Ortho-McNeil Pharmaceutical, Inc. (US) | 2003-01-02 | — | — | EP | claimed |
| US-20020006928-A1 | Phenyl-substituted indoles and indazoles | ORTHO MCNEIL PHARMACEUTICAL, INC. | 2002-01-17 | — | — | US | claimed |
| US-5705497-A | INOTROPIC, ANTIARRHYTHMIA AGENTS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1998-01-06 | — | — | US | claimed |
| EP-0121244-B1 | CEPHALOSPORIN DERIVATIVES | Bristol-Myers Company (US) | 1990-09-12 | — | — | EP | claimed |
| CN-1030760-A | The novel method of preparation cephem compounds and cephalosporin derivative | GIST BROCADES NV (NL) | 1989-02-01 | — | — | CN | claimed |
| EP-0148777-B1 | PHOSPHOLIPIDS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1988-07-27 | — | — | EP | claimed |
| US-4672119-A | AFFECT NEUROMUSCULAR IMPULSE TRANSMISSION; TOXIC; CHEMICAL WARFARE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1987-06-09 | — | — | US | claimed |
| US-4650791-A | ASTHMA | Takedo Chemical Industries, Ltd. (JP) | 1987-03-17 | — | — | US | claimed |
| EP-0171968-A1 | Use of a phospholipid derivative | Takeda Chemical Industries, Ltd. (JP) | 1986-02-19 | — | — | EP | claimed |
| EP-0148777-A2 | Phospholipids, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1985-07-17 | — | — | EP | claimed |
| US-4525473-A | BACTERICIDES | BRISTOL-MYERS COMPANY (US) | 1985-06-25 | — | — | US | claimed |
| EP-0121244-A2 | Cephalosporin derivatives | Bristol-Myers Company (US) | 1984-10-10 | — | — | EP | claimed |